The efficacy, immunogenicity and safety of the LZ901 vaccine for herpes zoster virus in adults 40 years of age or older: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Article Details
Authors (18)
Pengfei Jin
Department of Chemistry
Yaru Quan
Xuefeng Gao
Mingwei Wei
Xiang Cao
State Key Laboratory of Flexible Electronics (LoFE), Institute of Advanced Materials (IAM), Jiangsu National Synergetic Innovation Center for Advanced Materials (SICAM), School of Materials Science and Engineering
Hongxing Pan
Heng Shen
Lei Zhao
School of Life Sciences, Key Laboratory of Pesticide and Chemical Biology of Ministry of Education, and Hubei Key Laboratory of Genetic Regulation and Integrative Biology, Central China Normal University
Qing Xu
Zhao Wang
State Key Laboratory of Bioinspired Interfacial Materials Science, State and Local Joint Engineering Laboratory for Novel Functional Polymeric Materials, Jiangsu Key Laboratory of Advanced Functional Polymer Materials, Suzhou Key Laboratory of Macromolecular Design and Precision Synthesis, College of Chemistry, Chemical Engineering and Materials Science
Xiaodong Liu
Jinmei Xu
Kangwei Xu
School of Pharmaceutical Sciences
Wenyan Wan
Yeqing Tong
Li Zhang
Songtao Xu
Jingxin Li